LYZ and bacterial infectious disease: According to the authors [78], another fungal lysozyme, produced by the Chalaropsis species, could be utilized in a variety of settings where bacterial infections proliferate, such as hospital settings (S. aureus) or in veterinary applications (mastitis from S. aureus in cows), and as a means of combating bioterror agents (such as Staphylococcal Enterotoxin B and Clostridium botulinum).